Literature DB >> 34226678

Canonical Wnt signaling in the kidney in different hypertension models.

Irena Kasacka1, Zaneta Piotrowska2, Natalia Domian2, Magdalena Acewicz2, Alicja Lewandowska2.   

Abstract

There is a close relationship between the kidney and blood pressure. On the one hand, kidney dysfunction causes an increase in blood pressure; on the other hand, high blood pressure causes kidney dysfunction. Wnt/β-catenin signaling is a key pathway that regulates various cellular processes and tissue homeostasis and is also involved in damage and repair processes. In healthy organs, Wnt/β-catenin signaling is muted, but it is activated in pathological states. The purpose of the present study was to immunohistochemically evaluate and compare the expression of WNT4, WNT10A, Fzd8, β-catenin, and GSK-3ß (glycogen synthase kinase 3β) in the kidneys of rats with essential arterial hypertension (SHR), renal-renal hypertension (2K1C), and DOCA-salt-induced hypertension. The study was performed on five male WKY rats, seven SHRs, and twenty-four (n = 24) young male Wistar rats. The main results showed that during hypertension, there are changes in Wnt/β-catenin signaling in the kidneys of rats, and the severity of these changes depends on the type of hypertension. This study is the first to assess the levels of some elements of the canonical Wnt/β-catenin signal transduction pathway in various types of arterial hypertension by immunohistochemistry and may form the basis for further molecular and functional studies of this pathway in hypertension.
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Hypertension.; Kidney; Wnt/β-catenin signaling

Mesh:

Substances:

Year:  2021        PMID: 34226678     DOI: 10.1038/s41440-021-00689-z

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  36 in total

1.  Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney.

Authors:  William J Welch; Margarida Mendonca; Shakil Aslam; Christopher S Wilcox
Journal:  Hypertension       Date:  2003-01-20       Impact factor: 10.190

Review 2.  The Kidney in Hypertension.

Authors:  Hillel Sternlicht; George L Bakris
Journal:  Med Clin North Am       Date:  2017-01       Impact factor: 5.456

3.  Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Yuki Suzaki; Akira Nishiyama
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

4.  [The hydrolysis kinetics of pyridine carboxylic acid anhydride].

Authors:  H J Nestler; J K Seydel
Journal:  Chem Ber       Date:  1967

5.  Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury.

Authors:  K F Hilgers; A Hartner; M Porst; M Mai; M Wittmann; C Hugo; D Ganten; H Geiger; R Veelken; J F Mann
Journal:  Kidney Int       Date:  2000-12       Impact factor: 10.612

6.  Association of renal injury with nitric oxide deficiency in aged SHR: prevention by hypertension control with AT1 blockade.

Authors:  Xin Joseph Zhou; Nosratola D Vaziri; Jianwei Zhang; Hong W Wang; Xiu Q Wang
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

7.  Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic changes.

Authors:  S Kobayashi; A Ishida; H Moriya; N Mori; T Fukuda; T Takamura
Journal:  J Lab Clin Med       Date:  1999-02

8.  Early interstitial changes in hypertension-induced renal injury.

Authors:  M Mai; H Geiger; K F Hilgers; R Veelken; J F Mann; J Dämmrich; F C Luft
Journal:  Hypertension       Date:  1993-11       Impact factor: 10.190

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Hypertension       Date:  2003-11       Impact factor: 10.190

10.  Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet.

Authors:  Chang-De Zhan; Ram K Sindhu; Jason Pang; Ashkan Ehdaie; Nosratola D Vaziri
Journal:  J Hypertens       Date:  2004-10       Impact factor: 4.844

View more
  2 in total

Review 1.  Update on Hypertension Research in 2021.

Authors:  Masaki Mogi; Tatsuya Maruhashi; Yukihito Higashi; Takahiro Masuda; Daisuke Nagata; Michiaki Nagai; Kanako Bokuda; Atsuhiro Ichihara; Yoichi Nozato; Ayumi Toba; Keisuke Narita; Satoshi Hoshide; Atsushi Tanaka; Koichi Node; Yuichi Yoshida; Hirotaka Shibata; Kenichi Katsurada; Masanari Kuwabara; Takahide Kodama; Keisuke Shinohara; Kazuomi Kario
Journal:  Hypertens Res       Date:  2022-07-05       Impact factor: 5.528

2.  Wnt/β-catenin signaling in the adrenal glands of rats in various types of experimental hypertension.

Authors:  Irena Kasacka; Żaneta Piotrowska; Natalia Domian; Alicja Lewandowska
Journal:  Endocr Connect       Date:  2022-07-19       Impact factor: 3.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.